NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Press Enter or click the Search button to begin your search.

Back to Results
Universal fieldable assay with unassisted visual detectionA universal detection system based on allosteric aptamers, signal amplification cascade, and eye-detectable phrase transition. A broadly applicable homogeneous detection system is provided. It utilizes components of the blood coagulation cascade in the presence of polystyrene microspheres (MS) as a signal amplifier. Russell's viper venom factor X activator (RVV-X) triggers the cascade, which results in an eye-visible phase transition--precipitation of MS bound to clotted fibrin. An allosteric RNA aptamer, RNA132, with affinity for RVV-X and human vascular endothelial growth factor (VEGF.sub.165) was created. RNA132 inhibits enzymatic activity of RVV-X. The effector molecule, VEGF.sub.165, reverses the inhibitory activity of RNA132 on RVV-X and restores its enzymatic activity, thus triggering the cascade and enabling the phase transition. Similar results were obtained for another allosteric aptamer modulated by a protein tyrosine phosphatase. The assay is instrumentation-free for both processing and readout.
Document ID
20130001592
Acquisition Source
Ames Research Center
Document Type
Other - Patent
Authors
Chelyapov, Nicolas
Date Acquired
August 27, 2013
Publication Date
December 4, 2012
Subject Category
Aerospace Medicine
Report/Patent Number
Patent Number: US-Patent-8,324,357
Patent Application Number: US-Patent-Appl-SN-11/682,796
Funding Number(s)
CONTRACT_GRANT: NCC2-1224
Distribution Limits
Public
Copyright
Work of the US Gov. Public Use Permitted.
Patent
US-Patent-8,324,357
Patent Application
US-Patent-Appl-SN-11/682,796
No Preview Available